Advanced Search
Current and Breaking News for Professionals, Consumers and Media



Click here to learn how to advertise on this site and for ad rates.

Alzheimer Issues Author: Staff Editor Last Updated: Nov 20, 2017 - 7:40:06 AM



Benzodiazepines Increase Mortality in Persons with Alzheimer’s Disease

By Staff Editor
Nov 20, 2017 - 7:31:57 AM



Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Ezine
For Email Marketing you can trust


Email this article
 Printer friendly page

(HealthNewsDigest.com) - Benzodiazepine and related drug use is associated with a 40 per cent increase in mortality among persons with Alzheimer’s disease, according to a new study from the University of Eastern Finland. The findings were published in the International Journal of Geriatric Psychiatry.

The study found that the risk of death was increased right from the initiation of benzodiazepine and related drug use. The increased risk of death may result from the adverse events of these drugs, including fall-related injuries, such as hip fractures, as well as pneumonia and stroke.

The study was based on the register-based MEDALZ (Medication Use and Alzheimer’s Disease) cohort, which includes all persons diagnosed with Alzheimer’s disease in Finland during 2005-2011. Persons who had used benzodiazepines and related drugs previously were excluded from this study, and therefore, the study population consisted of 10,380 new users of these drugs. They were compared with 20,760 persons who did not use these drugs.

Although several treatment guidelines state that non-pharmacological options are the first-line treatment of anxiety, agitation and insomnia in persons with dementia, benzodiazepines and related drugs are frequently used in the treatment of these symptoms. If benzodiazepine and related drug use is necessary, these drugs are recommended for short-term use only. These new results encourage more consideration for benzodiazepine and related drug use in persons with dementia.

For further information, please contact:

Laura Saarelainen, Early Stage Researcher, University of Eastern Finland, School of Pharmacy, laura.saarelainen(at)uef.fi

Research article:



Top of Page

HealthNewsDigest.com

Alzheimer Issues
Latest Headlines


+ What You Need to Know about Alzheimer's
+ Innovative Couples’ Intervention Significantly Helps People With Alzheimer’s Communicate
+ Data Detectives Shift Suspicions in Alzheimer's from Usual Suspect to Inside Villain
+ Researchers Successfully Reverse Alzheimer’s Disease in Mouse Model
+ Deep Brain Stimulation Slows Alzheimer’s Decline
+ Exercise Can Improve Alzheimer’s Symptoms
+ Different Culprit Behind Alzheimer's Disease
+ Body Clock Disruptions Occur Years Before Memory Loss in Alzheimer’s
+ Alzheimer’s Drug Turns Back Clock in Powerhouse of Cell
+ Planes, Trains, and Automobiles: How a Team of Traveling Mice are Advancing the Alzheimer's Cause



Contact Us | Job Listings | Help | Site Map | About Us
Advertising Information | HND Press Release | Submit Information | Disclaimer

Site hosted by Sanchez Productions